Back to Trades
Jahr Robert Charles
Chief Executive OfficerDirectorCIK 0002076177
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Jahr Robert Charles, Chief Executive Officer, Director, accounts for 3 disclosed filings worth $1.6M, all concentrated in Outlook Therapeutics, Inc. (OTLK), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Aug 14 | OTLK Outlook Therapeutics, Inc. | Jahr Robert Charles | Chief Executive Officer, Director | Buy | $166.7K |
| Jul 23 | OTLK Outlook Therapeutics, Inc. | Jahr Robert Charles | Chief Executive Officer, Director | Award | $143.0K |
| Jul 9 | OTLK Outlook Therapeutics, Inc. | Jahr Robert Charles | Insider | Award | $1.3M |
3 filings